A Proof-Of-Concept Study Evaluating the Effect of ADX10059, a Metabotropic Glutamate Receptor-5 Negative Allosteric Modulator, on Acid Exposure and Symptoms in Gastro-Oesophageal Reflux Disease
Gut - United Kingdom
doi 10.1136/gut.2008.162040
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 20, 2009
Authors
Publisher
BMJ